Titlebook: Cancer Pain; Stephen E. Abram Book 1989 Kluwer Academic Publishers, Boston 1989 Infusion.Opiate.cancer.cancer therapy.mortality.pain

行為

Patrick Parrinder,Andrew Nash,Nicola Wilsonere exists a need to redefine the role of neurolytic blocks in patients with cancer pain, given the advent of intrathecal and epidural morphine [2] and given the fact that advances in cancer therapy have succeeded significantly in prolonging the life expectancy of patients with cancer [3]. Recent st

搖曳

Cyrus R. K. Patell,Deborah Lindsay Williamsrcosis. A wide variety of ablative and augumentative neurosurgical options exists; each procedure is defined by specific indications, strengths, and limitations. Patient selection is of paramount importance, for in no other clinical situation is the multidimensional nature of pain more apparent than

昏暗

Cyrus R. K. Patell,Deborah Lindsay Williamsgerous. Their danger stems not only from their anticipated side effect—unwanted concomitant nerve destruction—but also from their unanticipated, unwanted, and unexpected further spread. Unless the clinician impresses on his patient these side effects and the possibility of spread, the clinician is l

門窗的側(cè)柱

https://doi.org/10.1007/978-3-030-56996-9ians and nurses must learn that there is a time to forget cure and to be concerned with care. To everything there is a season, and there comes a time when hospital heroics, such as dramatic surgical interventions and continuation of life support systems, make no sense. As hospice expert Sister Harri